Literature DB >> 12393864

Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease.

Laurent Muller1, Alain Barret, Eric Etienne, Rina Meidan, Olivier Valdenaire, Pierre Corvol, Claude Tougard.   

Abstract

Endothelin-converting enzyme (ECE) is a membrane metalloprotease that generates endothelin from its direct precursor big endothelin. Four isoforms of ECE-1 are produced from a single gene through the use of alternate promoters. These isoforms share the same extracellular catalytic domain and contain unique cytosolic tails, which results in their specific subcellular targeting. We investigated the distribution of ECE-1 isoforms in transfected AtT-20 neuroendocrine cells. Whereas ECE-1a and 1c were present at the plasma membrane, ECE-1b and ECE-1d were retained inside the cells. We found that both intracellular isoforms were concentrated in the endosomal system: ECE-1d in recycling endosomes, and ECE-1b in late endosomes/multivesicular bodies. Leucine-based motifs were involved in the intracellular retention of these isoforms, and the targeting of ECE-1b to the degradation pathway required an additional signal in the N terminus. The concentration of ECE-1 isoforms in the endosomal system suggested new functions for these enzymes. Potential novel functions include redistribution of other isoforms through direct interaction. We have showed that ECE-1 isoforms could heterodimerize, and that in such heterodimers the ECE-1b targeting signal was dominant. Interaction of a plasma membrane isoform with ECE-1b resulted in its intracellular localization and decreased its extracellular activity. These data demonstrated that the targeting signals specific for ECE-1b constitute a regulatory domain per se that could modulate the localization and the activity of other isoforms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393864     DOI: 10.1074/jbc.M208949200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Association of endothelin-converting enzyme-1b C-338A polymorphism with increased risk of ischemic stroke in Chinese Han population.

Authors:  Rui Li; Min Cui; Jin Zhao; Mingming Yu; Zegang Ying; Shiming Zhou; Huadong Zhou
Journal:  J Mol Neurosci       Date:  2013-09-13       Impact factor: 3.444

2.  Regulation of vascular contractility and blood pressure by the E2F2 transcription factor.

Authors:  Junlan Zhou; Yan Zhu; Min Cheng; Deepika Dinesh; Tina Thorne; Kian Keong Poh; Dongxu Liu; Chantal Botros; Yao Liang Tang; Nichole Reisdorph; Raj Kishore; Douglas W Losordo; Gangjian Qin
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

3.  Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ.

Authors:  Peng-Le Yao; Shu Zhuo; Hong Mei; Xiao-Fang Chen; Na Li; Teng-Fei Zhu; Shi-Ting Chen; Ji-Ming Wang; Rui-Xing Hou; Ying-Ying Le
Journal:  CNS Neurosci Ther       Date:  2017-09-20       Impact factor: 5.243

4.  Increased immunoreactivities against endothelin-converting enzyme-1 and monocyte chemotactic protein-1 in hepatic stellate cells of rat fibrous liver induced by thioacetamide.

Authors:  Takahisa Nagata; Hideaki Kudo; Tomoko Nishino; Yoshiaki Doi; Hideaki Itoh; Sunao Fujimoto
Journal:  Med Mol Morphol       Date:  2005-09       Impact factor: 2.309

5.  Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.

Authors:  Robert J Baranello; Krishna L Bharani; Vasudevaraju Padmaraju; Nipun Chopra; Debomoy K Lahiri; Nigel H Greig; Miguel A Pappolla; Kumar Sambamurti
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

6.  Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice.

Authors:  Niki C Carty; Kevin Nash; Daniel Lee; Mary Mercer; Paul E Gottschall; Craig Meyers; Nicholas Muzyczka; Marcia N Gordon; Dave Morgan
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

7.  Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes.

Authors:  Javier Pacheco-Quinto; Elizabeth A Eckman
Journal:  J Biol Chem       Date:  2013-01-02       Impact factor: 5.157

8.  Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.

Authors:  Dirk Roosterman; Graeme S Cottrell; Benjamin E Padilla; Laurent Muller; Christopher B Eckman; Nigel W Bunnett; Martin Steinhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

9.  Endothelin-converting enzyme 1 promotes re-sensitization of neurokinin 1 receptor-dependent neurogenic inflammation.

Authors:  F Cattaruzza; G S Cottrell; N Vaksman; N W Bunnett
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

10.  Protein Kinase C Regulates the Cell Surface Activity of Endothelin-Converting Enzyme-1.

Authors:  A Ian Smith; Rebecca A Lew; Walter G Thomas; Nathalie Tochon-Danguy
Journal:  Int J Pept Res Ther       Date:  2006-05-19       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.